- Home
- YIBO vs TLSI Comparison
YIBO vs TLSI Comparison
Compare YIBO & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YIBO
- TLSI
- Stock Information
- Founded
- YIBO 2011
- TLSI 2010
- Country
- YIBO China
- TLSI United States
- Employees
- YIBO N/A
- TLSI N/A
- Industry
- YIBO
- TLSI Medical Specialities
- Sector
- YIBO
- TLSI Health Care
- Exchange
- YIBO NYSE
- TLSI Nasdaq
- Market Cap
- YIBO 152.5M
- TLSI 124.9M
- IPO Year
- YIBO 2024
- TLSI N/A
- Fundamental
- Price
- YIBO $3.70
- TLSI $3.93
- Analyst Decision
- YIBO
- TLSI Strong Buy
- Analyst Count
- YIBO 0
- TLSI 5
- Target Price
- YIBO N/A
- TLSI $12.10
- AVG Volume (30 Days)
- YIBO 15.0K
- TLSI 25.0K
- Earning Date
- YIBO 11-22-2024
- TLSI 11-14-2024
- Dividend Yield
- YIBO N/A
- TLSI N/A
- EPS Growth
- YIBO N/A
- TLSI N/A
- EPS
- YIBO 0.17
- TLSI N/A
- Revenue
- YIBO $153,281,000.00
- TLSI $26,892,000.00
- Revenue This Year
- YIBO N/A
- TLSI $61.76
- Revenue Next Year
- YIBO N/A
- TLSI $47.30
- P/E Ratio
- YIBO $21.61
- TLSI N/A
- Revenue Growth
- YIBO 5.90
- TLSI 67.92
- 52 Week Low
- YIBO $1.80
- TLSI $3.32
- 52 Week High
- YIBO $7.83
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- YIBO 60.94
- TLSI 39.39
- Support Level
- YIBO $2.91
- TLSI $3.74
- Resistance Level
- YIBO $4.08
- TLSI $4.66
- Average True Range (ATR)
- YIBO 0.26
- TLSI 0.29
- MACD
- YIBO 0.05
- TLSI 0.02
- Stochastic Oscillator
- YIBO 66.67
- TLSI 20.77
About YIBO PLANET IMAGE INTERNATIONAL LIMITED
Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under three brands, TrueImage, CoolToner, and AZtech. The company operates in North America, Europe, and Other countries.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.